This is the authors' abstract. We don't add key points for this paper.
Life-threatening hemorrhages occur in about 2% of children with idiopathic thrombocytopenic purpura (ITP), the majority during the first month of illness. The administration of corticosteroids to patients with ITP has been shown to improve platelet economy mainly through reduction of phagocytosis in the spleen. Since the risk of a short course of steroids in low dosage is small, it seems reasonable to administer them to patients with ITP during the period of greatest risk.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
P. D. McClure (1977) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: